Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness
Ciro Andolfi, Jeffrey Bloodworth, Apostolos Papachristos, et al.
Bladder Cancer (2020) Vol. 6, Iss. 3, pp. 225-235
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Urinary Tract Infections: The Current Scenario and Future Prospects
Giuseppe Mancuso, Angelina Midiri, Elisabetta Gerace, et al.
Pathogens (2023) Vol. 12, Iss. 4, pp. 623-623
Open Access | Times Cited: 162
Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases
Oana-Alina Petrariu, Ilda Czobor Barbu, Adelina-Gabriela Niculescu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 53
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample
Carmela Nardelli, Achille Aveta, Savio Domenico Pandolfo, et al.
European Urology Open Science (2023) Vol. 59, pp. 18-26
Open Access | Times Cited: 29
Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention
Enrique Almanza‐Aguilera, Ainara Cano, Mercedes Gil‐Lespinard, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 103-119
Open Access | Times Cited: 28
Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges
Georgios Papavasileiou, Dimitrios Tsilingiris, Nikolaos Spyrou, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 70-98
Closed Access | Times Cited: 23
Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review
A Russo, Areeba Memon, Shahid Ahmed
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 2, pp. 434-444
Closed Access | Times Cited: 7
An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer
Jacob Knorr, Zaeem Lone, Glenn T. Werneburg, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 9, pp. 291.e1-291.e11
Closed Access | Times Cited: 6
The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
Wei Tse Li, Anjali Iyangar, Rohan G. Reddy, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3649-3649
Open Access | Times Cited: 37
Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway
Yu-Hang Zhang, Wenyu Wang, Hang Zhou, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 809-809
Open Access | Times Cited: 11
Quinolones as a Potential Drug in Genitourinary Cancer Treatment—A Literature Review
Tomasz Kloskowski, Sylwia Frąckowiak, Jan Adamowicz, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients
Avery Braun, Mengying Deng, Jill S. Hasler, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Progress in Probiotic Science: Prospects of Functional Probiotic‐Based Foods and Beverages
Musaalbakri Abdul Manan
International Journal of Food Science (2025) Vol. 2025, Iss. 1
Open Access
The Urinary Microbiome: Role in Bladder Cancer and Treatment
Veronika Friedrich, Hae Woong Choi
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2068-2068
Open Access | Times Cited: 16
Is the Urinary and Gut Microbiome Associated With Bladder Cancer?
Joanna Chorbińska, Wojciech Krajewski, Łukasz Nowak, et al.
Clinical Medicine Insights Oncology (2023) Vol. 17
Open Access | Times Cited: 8
Microbiota-induced inflammatory responses in bladder tumors promote epithelial-mesenchymal transition and enhanced immune infiltration
Qiang Li, Yichao Sun, Kun Zhai, et al.
Physiological Genomics (2024) Vol. 56, Iss. 8, pp. 544-554
Closed Access | Times Cited: 3
Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol
Uwe Bieri, Michael Scharl, Silvan Sigg, et al.
BMJ Open (2022) Vol. 12, Iss. 4, pp. e061421-e061421
Open Access | Times Cited: 12
Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of Non-Muscle Invasive Bladder Cancer
J.J. Szczesniewski, Magaly-Teresa Márquez-Sánchez, Bárbara Padilla‐Fernández, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 3, pp. 102048-102048
Open Access | Times Cited: 2
Microbiome and bladder cancer: the role of probiotics in treatment
Leila Dadgar-Zankbar, Maryam Mokhtaryan, Elnaz Bafandeh, et al.
Future Microbiology (2024) Vol. 20, Iss. 1, pp. 73-90
Closed Access | Times Cited: 2
The Association of Prostate Cancer and Urinary Tract Infections: A New Perspective of Prostate Cancer Pathogenesis
Szu-Ying Pan, Wen‐Chi Chen, Chi‐Ping Huang, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 483-483
Open Access | Times Cited: 5
Influence of microbiome in intraprostatic inflammation and prostate cancer
Pranav Prakash, Shiv Verma, Sanjay Gupta
The Prostate (2024) Vol. 84, Iss. 13, pp. 1179-1188
Closed Access | Times Cited: 1
Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response
Mahgol Golshani, John A. Taylor, Benjamin L. Woolbright
Urologic Oncology Seminars and Original Investigations (2024)
Open Access | Times Cited: 1
Predictive Molecular Biomarkers of Bladder Cancer Identified by Next-Generation Sequencing—Preliminary Data
Aleksander Myszka, Marek Cieśla, A Siekierzyńska, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7701-7701
Open Access | Times Cited: 1
Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer
Sourav Kumar Nandi, S. Basu, Anish Bhattacharjya, et al.
Nutrition (2022) Vol. 103-104, pp. 111787-111787
Closed Access | Times Cited: 6
Microbiome in Bladder Cancer: A Systematic Review
Yong Nam Gwon, Jae-Joon Park, Ki-Soo Lee, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 84-84
Open Access | Times Cited: 5
The Urogenital System’s Role in Diseases: A Synopsis
Maroun Bou Zerdan, Rita Moukarzel, Nour Sabiha Naji, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3328-3328
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top